Invention Grant
US09126929B2 (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form II and preparation method therefor
有权
(S)-4-羟基-2-氧代-1-吡咯烷乙酰胺外消旋体晶型II及其制备方法
- Patent Title: (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form II and preparation method therefor
- Patent Title (中): (S)-4-羟基-2-氧代-1-吡咯烷乙酰胺外消旋体晶型II及其制备方法
-
Application No.: US14237894Application Date: 2012-04-24
-
Publication No.: US09126929B2Publication Date: 2015-09-08
- Inventor: Lei Ye
- Applicant: Lei Ye
- Applicant Address: CN Chongqing
- Assignee: Chongqing Runze Pharmaceutical Co., Ltd.
- Current Assignee: Chongqing Runze Pharmaceutical Co., Ltd.
- Current Assignee Address: CN Chongqing
- Agent Leong C. Lei
- Priority: CN201110230244 20110811
- International Application: PCT/CN2012/074582 WO 20120424
- International Announcement: WO2013/020391 WO 20130214
- Main IPC: C07D207/273
- IPC: C07D207/273

Abstract:
An (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide racemate referred to as (S)-oxiracetam crystal form II has a diffraction peak at a diffraction angle 2θ of 10.669, 13.25, 13.847, 14.198, 16.729, 17.934, 18.746, 18.816, 20.273, 20.413, 21.431, 21.617, 21.663, 23.38, 24.324, 24.415, 26.069, 26.107, 27.901, 28.621, 28.925, 29.449, 29.484, 31.702, 36.516, 37.685, or 39.721 degrees. The purity of the (S)-oxiracetam crystal form II can be up to 98.5%, and the (S)-oxiracetam crystal form II has the advantages of simple preparation method, mild control condition, low production cost, and the produced oxiracetam hydrate crystal form II has a high purity (the oxiracetam hydrate crystal form having a purity of 8%˜98.5% can be prepared by a crude levo-oxiracetam having a purity of 92%, and thus having a good reproducibility in production.
Public/Granted literature
- US20140235871A1 (S)-4-HYDROXY-2-OXO-1-PYRROLIDINEACETAMIDE RACEMATE CRYSTAL FORM II AND PREPARATION METHOD THEREFOR Public/Granted day:2014-08-21
Information query
IPC分类: